Quarterly report (Form 10-Q)
Boston Scientific 10-Q for Quarter ended Sep 30, 2026
Filing excerpt
During the first nine months of 2026, cash provided by (used for) investing activities included net cash payments of $930 million for acquisitions of multiple businesses, primarily related to Nalu Medical, Inc. and Scivita Medical Technology Co., Ltd., net payments for investments and acquisitions of certain technologies of $1.545 billion, primarily related to the investment in MiRus LLC (MiRus), and purchases of property, plant and equipment and internal use software of $552 million.